Literature DB >> 26269376

Australian survey on current practices for breast radiotherapy.

Kylie L Dundas1,2,3, Elise M Pogson1,2,3, Vikneswary Batumalai2,4, Miriam M Boxer2,4, Mei Ling Yap2,3,4,5, Geoff P Delaney2,3,4,5, Peter Metcalfe1,2,3, Lois Holloway1,2,3,4,6.   

Abstract

INTRODUCTION: Detailed, published surveys specific to Australian breast radiotherapy practice were last conducted in 2002. More recent international surveys specific to breast radiotherapy practice include a European survey conducted in 2008/2009 and a Spanish survey conducted in 2009. Radiotherapy techniques continue to evolve, and the utilisation of new techniques, such as intensity-modulated radiation therapy (IMRT), is increasing. This survey aimed to determine current breast radiotherapy practices across Australia.
METHOD: An online survey was completed by 50 of the 69 Australian radiation therapy treatment centres.
RESULTS: Supine tangential beam whole breast irradiation remains the standard of care for breast radiotherapy in Australia. A growing number of institutions are exploring prone positioning and IMRT utilisation. This survey demonstrated a wide variation in the benchmarks used to limit and report organ at risk doses, prescribed dose regimen, and post-mastectomy bolus practices. This survey also indicated, when compared with international literature, that there may be less interest in or uptake of external beam partial breast irradiation, prone positioning, simultaneous integrated boost and breath hold techniques. These are areas where further review and research may be warranted to ensure Australian patients are receiving the best care possible based on the best evidence available.
CONCLUSION: This survey provides insight into the current radiotherapy practice for breast cancer in Australia.
© 2015 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  breast cancer; clinical practice; radiotherapy; survey

Mesh:

Year:  2015        PMID: 26269376     DOI: 10.1111/1754-9485.12348

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  5 in total

Review 1.  Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy.

Authors:  Martin Schmitt; Jordan Eber; Delphine Antoni; Georges Noel
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

2.  Movement assessment of breast and organ-at-risks using free-breathing, self-gating 4D magnetic resonance imaging workflow for breast cancer radiation therapy.

Authors:  Melanie Habatsch; Manuel Schneider; Martin Requardt; Sylvain Doussin
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-14

3.  Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.

Authors:  Benjamin T Cooper; Xiaochun Li; Samuel M Shin; Aram S Modrek; Howard C Hsu; J K DeWyngaert; Gabor Jozsef; Stella C Lymberis; Judith D Goldberg; Silvia C Formenti
Journal:  Adv Radiat Oncol       Date:  2016-08-09

4.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Authors:  Charlotte E Coles; Clare L Griffin; Anna M Kirby; Jenny Titley; Rajiv K Agrawal; Abdulla Alhasso; Indrani S Bhattacharya; Adrian M Brunt; Laura Ciurlionis; Charlie Chan; Ellen M Donovan; Marie A Emson; Adrian N Harnett; Joanne S Haviland; Penelope Hopwood; Monica L Jefford; Ronald Kaggwa; Elinor J Sawyer; Isabel Syndikus; Yat M Tsang; Duncan A Wheatley; Maggie Wilcox; John R Yarnold; Judith M Bliss
Journal:  Lancet       Date:  2017-08-02       Impact factor: 79.321

5.  MRI geometric distortion: Impact on tangential whole-breast IMRT.

Authors:  Amy Walker; Peter Metcalfe; Gary Liney; Vikneswary Batumalai; Kylie Dundas; Carri Glide-Hurst; Geoff P Delaney; Miriam Boxer; Mei Ling Yap; Jason Dowling; David Rivest-Henault; Elise Pogson; Lois Holloway
Journal:  J Appl Clin Med Phys       Date:  2016-09       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.